Androgen supplementation in eugonadal men with osteoporosis: Effects of six months' treatment on markers of bone formation and resorption

Journal of Bone and Mineral Research

Volumn 12, Issue 3, 1997, Pages 472-478

  Anderson, F H ^a,c   Francis, R M ^a   Peaston, R T ^a   Wastell, H J ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; ESTRADIOL; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; SUSTANON 250; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; DRUG EFFECT; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; VERTEBRA FRACTURE;

EID: 0030899249     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.3.472     Document Type: Article

References (38)

1. Melton LJ, Chrischilles EA, Cooper C, Lane AW, Riggs BL 1992 How many women have osteoporosis? J Bone Miner Res 7:1005-1010.
2. Royal College of Physicians of London 1989 Fractured neck of femur: Prevention and management. Royal College of Physicians of London, London, U.K.
3. Boyce WJ, Vessey MP 1985 Rising incidence of fracture of the proximal femur. Lancet 1:150-151.
4. Obrant KJ, Bengner U, Johnell O, Nilsson BE, Sernbo 11989 Increasing age-adjusted risk of fragility fractures: A sign of increasing osteoporosis in successive generations? Calcif Tissue Int 44:157-167.
5. Scane AC, Sutcliffe AM, Francis RM 1994 The sequelae of vertebral crush fractures in men. Osteoporosis Int 4:89-92.
6. Cooper C 1993 Epidemiology and public health impact of osteoporosis. In: Reid D (ed.) Bailliere's Clinical Rheumatology: Osteoporosis, Vol 7, Number 3, pp. 459-478.
7. Baillie SP, Davison CE, Johnson FJ, Francis RM 1992 Pathogenesis of vertebral crush fractures in men. Age Ageing 21:139-141.
8. Jackson JA, Spiekerman AM 1989 Testosterone deficiency is common in men with hip fracture after simple falls. Clin Res 37:131.
9. Stanley HL, Schmitt BP, Poses RM, Deiss WP 1991 Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 39:766-771.
10. Štěpán JJ, Lachman M, Zvěřina J, Pacovský V, Baylink DJ 1989 Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab 69:523-527.
11. Horowitz M, Wishart JM, O'Loughin PD, Morris HA, Need AG, Nordin BEC 1992 Osteoporosis and Klinefelter's syndrome. Clin Endocrinol 36:113-118.
12. Francis RM, Peacock M, Aaron JE, Selby DL, Taylor GL, Thompson J, et al. 1986 Osteoporosis in hypogonadal men: Role of decreased plasma 1,25-dihydroxy-vitamin D, calcium malabsorption and low bone formation. Bone 7:261-268.
13. Foresta C, Busnardo B, Ruzza G, Zanatta G, Mioni R 1983 Lower calcitonin levels in young hypogonadic men with osteoporosis. Hormone Metab Res 15:206-207.
14. Vanderschueren D, Bouillon R 1995 Androgens and bone. Calcif Tissue Int 56:341-346.
15. Scane AC, Francis RM, Johnson FJ, Davison CE 1992 The effects of testosterone treatment in eugonadal men with osteoporosis. In: Ring EFJ (ed.) Current research in osteoporosis and bone mineral measurement II. British Institute of Radiology, London, U.K., p. 54.
16. Anderson FH, Francis RM, Faulkner K 1996 Androgen supplementation in eugonadal men with osteoporosis: Effects of six months' treatment on bone mineral density and cardiovascular risk factors. Bone 18:171-177.
17. Altman DG 1991 Practical statistics for medical research. Chapman & Hall, London, U.K., pp. 136-142.
18. Bland JM, Altman DG 1995 Multiple significance tests: The Bonferroni method. Br Med J 310:170.
19. Gore SM, Altman DG 1982 Statistics in Practice. British Medical Association, London, U.K., pp. 12-13.
20. Robins SP 1995 Markers of bone resorption. J Endocrinol 144(Suppl):S47.
21. Hangartner TN, Johnston CC 1990 Influence of fat on bone measurements with dual energy absorptiometry. Bone Miner 9:71-81.
22. Sloan JP, Wing P, Dian L, Meneilly GS 1992 A pilot study of anabolic steroids in elderly patients with hip fractures. J Am Geriatr Soc 40:1105-1111.
23. Lye MD, Ritch AE 1977 Long-term anabolic therapy in the elderly. Age Ageing 6:221-227.
24. Marin P, Krotkiewski M, Bjorntorp P 1992 Androgen treatment of middle-aged, obese men: Effects on metabolism, muscle and adipose tissues. Eur J Med 1:329-336.
25. Forbes GB, Porta CR, Herr BE, Griggs RC 1992 Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA 267:397-399.
26. Young NR, Baker HW, Liu G, Seeman E 1993 Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. J Clin Endocrinol Metab 77:1028-1032.
27. Hassager C, Podenphant J, Riis BJ, Johansen JS, Jensen J, Christiansen C 1989 Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women. Metab Clin Exper 38:238-242.
28. Friedl KE, Dettori JR, Hannan CJ Jr, Patience TH, Plymate SR 1991 Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men. J Steroid Biochem Mol Biol 40:607-612.
29. Khaw KT, Barrett-Connor E 1991 Endogenous sex hormones, high density lipoprotein cholesterol and other lipoprotein fractions in men. Arteriosclerosis Thrombosis 11:489-494.
30. Selby PL, Braidman IP, Mawer EB, Freemont AJ 1996 Hormonal influences in male osteoporosis. Osteoporosis Int 6(Suppl 1):279.
31. Geller J 1991 Benign prostatic hyperplasia: Pathogenesis and medical therapy. J Am Geriatr Soc 39:1208-1216.
32. Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ 1994 Physiological levels of estradiol stimulate plasma high density lipoprotein 2 cholesterol levels in normal men. J Clin Endocrinol Metab 78:855-861.
33. Zmuda JM, Fahrenbach MC, Younkin BT, Bausserman LL, Terry RB, Catlin DH, Thompson PD 1993 The effect of testosterone aromatization on high density lipoprotein cholesterol level and postheparin lipolytic activity. Metab Clin Exper 42:446-450.
34. Davis S, Wright PW, Schulman SF, Hill LD, Pinkham RD, Johnson LP et al. 1985 Participants in prospective randomised clinical trials for resected non-small cell lung cancer have improved survival compared with non-participants. Cancer 56:1710-1718.
35. Holmang S, Marin P, Lindstedt G, Hedelin H 1993 Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men. Prostate 23:99-106.
36. Jackson JA, Waxman J, Spiekerman AM 1989 Prostatic complications of testosterone replacement therapy. Arch Intern Med 149:2365-2366.
37. Matsumoto AM 1990 Effects of chronic testosterone administration in normal men: Safety and efficacy of high-dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone and sperm production. J Clin Endocrinol Metab 70:282-286.
38. Handelsman DJ, Farley TMM, Waites GMH 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 336:955-959.